THTamara S. Hannon

Tamara S. Hannon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tamara S. Hannon has a total of 140 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pilot, feasibility, and acceptability evaluation of a mindfulness-based intervention with diabetes education in adolescents with type 1 diabetes

    by Lauren A. Ray, Julie M. Pike, Luz A. Machuca, George J. Eckert, Patricia C. Broderick, Tamara S. Hannon

  • Open Access

    “It helps calm my mind”—Exploring the Connection of Religion, Spirituality, and Mindfulness in Adolescents With Diabetes

    by Daenique H. A. Jengelley, Luz A. Machuca, Geneva Baumberger, Shelley E. Varner-Perez, Tamara S. Hannon

    Background: Adolescents with diabetes participate in daily disease management tasks yet often have underdeveloped coping skills and lack consistent support. The negative emotional impact of diabetes is often associated with poor mental and physical health outcomes. Religious, spiritual, or mindfulness practices may augment coping strategies to support positive diabetes outcomes. Objective: We examined adolescents’ thoughts and beliefs about the relevance of religious, spiritual or mindfulness practices in their diabetes management. We inquired if a mindfulness-based intervention might be of interest as part of comprehensive diabetes education and treatment. Methods: Quantitative surveys—demographic, pediatric quality of life, and spiritual, religious, and personal beliefs—and qualitative interviews were conducted in 18 participants aged 14-18 years old to explore how religious, spiritual, or personal beliefs were perceived to impact coping with prediabetes, type 1, or type 2 diabetes. Results: Health-related quality of life was associated with spirituality, religious, and personal beliefs measured by (r=0.51, p =5.4x10 -10 ; r=0.61, p =1.01x10 -9 ). Most participants identified as having a religion, and their impressions of non-religious spiritual practices were varied. For all participants that engaged in spiritual practices (non-religious/religious), they believed these practices were beneficial for their mental health, but did not identify these practices as having an impact on diabetes management. Participants had limited knowledge of or familiarity with mindfulness practices and expressed apprehension when providing input about a potential mindfulness-based group intervention. Despite these concerns, participants voiced that mindfulness could be helpful for dealing with stress. Conclusion: Additional feasibility and acceptability work is needed to explore complementary therapies, such as mindfulness-based interventions, in adolescents with diabetes.

  • Open Access

    Diabetic ketoacidosis induced by long-acting growth hormone in a child without preexisting diabetes

    by Manahil Mustafa, Tamara S Hannon, John S Fuqua

    Long-acting growth hormone (LAGH) formulations improve medication adherence in children with growth hormone deficiency. Although transient insulin resistance and mild hyperglycemia are recognized effects of growth hormone therapy, diabetic ketoacidosis (DKA) in patients without prior diabetes is rare. We report a case of severe DKA shortly after initiation of lonapegsomatropin in an adolescent with hypopituitarism without preexisting glucose abnormalities. A 13-year-old boy with obesity, normal fasting glucose, and hypopituitarism receiving levothyroxine, hydrocortisone, and desmopressin replacement therapies following treatment of a suprasellar nongerminomatous germ cell tumor initiated treatment with lonapegsomatropin at 0.23 mg/kg/week. Two days after the administration of the first dose, he presented critically ill with hyperglycemia, severe metabolic acidosis, and ketonuria consistent with DKA. Hemoglobin A1c was 5.7% (reference range, <5.7%), type 1 diabetes autoantibodies were negative, and C-peptide was elevated, suggesting preserved endogenous insulin secretion. Diabetic ketoacidosis resolved with insulin and fluid therapy, and the patient remained normoglycemic after discontinuation of growth hormone therapy. This case suggests that acute LAGH-induced insulin resistance, potentially compounded by glucocorticoids and obesity, may precipitate transient DKA even in patients without prior glucose abnormalities. Close glucose monitoring should be considered when initiating LAGH therapy in high-risk patients.

  • Learning to Breathe With Type 2 Diabetes: A Pilot Feasibility and Acceptability Study of a Mindfulness-Based Intervention in Youth With Type 2 Diabetes or Prediabetes

    by Julie M. Pike, Jessica Yorgason, Luz A. Machuca, Patricia C. Broderick, Tamara S. Hannon

    OBJECTIVE: Mindfulness-based interventions (MBIs) support mental health. We evaluated the feasibility and acceptability of a 12-week MBI in adolescents with obesity and type 2 diabetes or prediabetes. RESEARCH DESIGN AND METHODS: This study was an uncontrolled, pilot, feasibility and acceptability evaluation in youth aged 15–17 years with type 2 diabetes or prediabetes. The Learning to BREATHE (L2B) curriculum was delivered via 12 virtual group sessions. Recruitment, retention, and attendance were tracked to measure feasibility. Acceptability was measured via postintervention satisfaction surveys. Questionnaires were administered pre- and postintervention and after 12 months for depression and anxiety symptoms and quality of life (PedsQL). RESULTS: Sixty-eight of 73 screened participants (93%) were eligible. By design, we enrolled the first 30 eligible participants who agreed and consented to participate. Three (10%) withdrew prior to L2B participation. Twenty-seven completed L2B (90% retention; 18 female; and 44% White, 41% Black, and 1% Hispanic race and ethnicity). The mean attendance was 8 of 12 sessions (67%). Survey completion was 100% pre-L2B, 93% post-L2B, and 81% 12 months post-L2B. Most participants agreed/strongly agreed that they felt supported (80%) and enjoyed the sessions (76%). Baseline depression and anxiety scores were within the normal range for the population and did not change from pre- to postintervention. Immediately following the intervention, the PedsQL score was higher (from 65 ± 20 to 70 ± 19). Sixteen participants had HbA1c and BMI measures corresponding to all three time points, and these were unchanged. CONCLUSIONS: A 12-week virtual group MBI was feasible and acceptable in adolescents with obesity and type 2 diabetes or prediabetes.

  • Open Access

    Long‐Term Glycemic Control and Pharmacotherapy in Type 2 Diabetes Mellitus: A Descriptive Analysis of 10‐Year Trends in a Statewide Sample

    by Helen N. Chen, Michael Weiner, Julian Wolfson, Tamara Hannon, Patrick Balius, Titus Schleyer

    Background: Little is known about prescribing and glycemic control trends for Type 2 diabetes (T2D) drug classes across populations. Objective: The aim of this study is to assess long‐term glycemic control in a statewide sample prescribed with T2D drugs. Design: Descriptive analysis of retrospective 10‐year cohort data from the Indiana Health Information Exchange in the United States. Participants: Adults with T2D were prescribed at least one diabetes drug. Main Measures: Glycemic success is the number of A1c < 7% for age < 65 or Results: Glycemic success was 60%, with year‐to‐year changes of 0%–1%. The prevalence of glycemic success was greater for females (mean of 62%–64%) than males (57%–59%); participants aged 65 or above (75%–89%) versus younger patients (43%–62%); and White (61%–63%) versus Black (51%–54%) patients. Biguanides (56%–63%) were most frequently prescribed, followed by sulfonylureas (29%–33%) and fast‐acting and long‐acting insulins (30%–32%). Black participants had more insulin prescriptions (47%–50%, vs. non‐Black, 9%–49%%). Newer drugs were more frequently prescribed for White than non‐White patients: 10%–17% versus 1.3%–17% for dipeptidyl peptidase 4 inhibitors; < 1%–9% versus 0.2%–8% for sodium/glucose cotransporter 2 inhibitors; and 5.3%–12% versus 1%–12% for glucagon‐like peptide receptor agonists. A greater number of diabetes drug classes ever prescribed was associated with lower glycemic success (1 class with 76%, vs. 2–3 classes with 55%, vs. 4–9 classes with 37%). Conclusions: Glycemic control did not substantively improve over a 10‐year period, despite the availability of new medications. Racial minorities received fewer prescriptions for newer drugs. Future research should examine factors contributing to prescription pattern differences and barriers to glycemic control.


  • A Tailored Approach to Increase Engagement in Lifestyle Change Programs in Women With Previous Gestational Diabetes Mellitus

    by Julie M. Pike, Noha El Yaman, Kathryn M. Haberlin-Pittz, Luz A. Machuca, Brett M. McKinney, Aric Kotarski, David M. Guise, Tamara S. Hannon

    OBJECTIVE: Most women with previous gestational diabetes mellitus (GDM) who are eligible for diabetes prevention programs are not referred and do not participate. We evaluated a tailored approach for program engagement in women with previous GDM. RESEARCH DESIGN AND METHODS: This feasibility study engaged women with previous GDM to discuss type 2 diabetes risk and select a program aligned with individual priorities. Seven lifestyle change programs, including the National Diabetes Prevention Program (NDPP) and two NDPP adaptations, were offered free of charge. We measured program selection and completion and clinical and psychosocial outcomes at baseline, 6 months (T1), and 12 months (T2). Descriptive statistics and paired t tests assessed changes over time. RESULTS: We consented 116 women (age 35.2 ± 5.6 years; 58.7% White; 46.8% college degree). Ninety-two participants were included in data analysis after exclusions because of pregnancy (n = 9), baseline BMI <25 (n = 11), baseline HbA1c ≥6.5 (n = 3), and illness (n = 1). Almost half of participants selected a commercial weight loss program (WW International, 41%), followed by a virtual NDPP (HabitNu, 22%), individual health coaching (11%), an in-person family-based NDPP adaptation (11%), a dietitian consult (9%), a clinic-based group program (5%), and an in-person NDPP (1%). Program completion was over 60%. Clinical and psychosocial outcomes were stable from baseline to T2. CONCLUSIONS: Lifestyle change program engagement was feasible in women with previous GDM, even during the coronavirus disease 2019 pandemic. Using informed decision-making strategies and a choice of lifestyle change programs to meet the unique priorities of women with previous GDM may optimize engagement.

  • Tailoring Teaching of Diabetes Self-Management Behaviors for Adults Facing Social and Economic Challenges: A Qualitative Study

    by Helen N. Chen, Robin Whittemore, Tamara Hannon, Michael Weiner, Titus Schleyer, Claire Draucker

    OBJECTIVE: Although health literacy interventions have been shown to increase knowledge, self-management behaviors, and glycemic control among patients with type 2 diabetes (T2D) who are facing social and economic challenges (SECs), research on their implementation in real-world primary care setting is limited. The objective of this study was to identify methods health professionals use to educate patients with T2D who are facing SECs, to improve their self-management behaviors. RESEARCH DESIGN AND METHODS: Health professionals (i.e., nurses, diabetes care and education specialists, primary care practitioners, pharmacists, and medical assistants) from three primary care clinics in the midwestern U.S. were recruited to share strategies they use to promote self-management behaviors among patients facing SECs. Semistructured individual interviews were conducted for this naturalistic inquiry guided by the Self- and Family Management Framework. Interviews were transcribed and coded for conventional content analysis. RESULTS: Twenty-nine health care professionals participated in the study. They described five methods to tailor teaching self-management behaviors to patients facing SECs: using multiple venues for education, tactics of simple language and repetition, visual aids, and the patient’s data as a teaching example; and personalizing recommendations. CONCLUSIONS: Health care professionals in primary care identified creative strategies tailored to the needs and strengths of individual patients to improve diabetes self-management understanding and behaviors.

  • Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial

    by Tamara S Hannon, Lily C Chao, Margarita Barrientos-Pérez, Karthik Chandrasekhar Pamidipati, Laura Fernández Landó, Clare J Lee, Hiren Patel, Brandon K Bergman


  • Insulin Dynamics and Pathophysiology in Youth-Onset Type 2 Diabetes

    by Rozan Abu-Nejem, Tamara S Hannon

    Youth-onset type 2 diabetes (T2D) is increasing around the globe. The mounting disease burden of youth-onset T2D portends substantial consequences for the health outcomes of young people and for health care systems. The pathophysiology of this condition is characterized by insulin resistance and initial insulin hypersecretion ± an inherent insulin secretory defect, with progressive loss of stimulated insulin secretion leading to pancreatic β-cell failure. Research studies focusing on youth-onset T2D have illuminated key differences for youth- vs adult-onset T2D, with youth having more profound insulin resistance and quicker progression to loss of sufficient insulin secretion to maintain euglycemia. There is a need for therapies that are targeted to improve both insulin resistance and, importantly, maintain sufficient insulin secretory function over the lifespan in youth-onset T2D.